Zika virus (ZIKV) first spread into Brazil in 2013 and is now present throughout the Americas. In 2016, Florida witnessed the beginnings of local ZIKV transmission. No reports of local transmission have been reported for 2018; however, travel related cases continue to be reported. Recurrence of local transmission in the United States is a major public health risk in Florida where vectors Aedes aegypti (Diptera: Culicidae, Linnaeus) and Aedes albopictus (Diptera: Culicidae, Skuse) are abundant and there is a high potential for virus reintroduction. A dose-response study was used to evaluate susceptibility and transmission potential of Florida Ae. aegypti and Ae. albopictus to ZIKV originating from Puerto Rico. Mosquitoes were orally exposed to one of three doses of ZIKV. Higher doses of infected blood resulted in overall greater infection rates in both mosquito species. Ae. aegypti and Ae. albopictus were susceptible to infection with ZIKV and revealed a significant species by dose interaction. At low doses, Ae. aegypti was significantly less susceptible to infection with ZIKV than Ae. albopictus (6.7% and 44.4%, respectively). In contrast, at high doses, Ae. aegypti was significantly more susceptible to infection than Ae. albopictus (75.8% and 53.8%, respectively). No significant differences were observed between Ae. aegypti and Ae. albopictus in disseminated infection (0-75%) and saliva infection (0-52.4%). These observations suggest greater susceptibility to infection for Ae. albopictus at lower doses likely encountered by viremic humans. However, low disseminated infection and saliva infection for Ae. albopictus, combined with catholic feeding behavior, are likely to limit transmission potential relative to Ae. aegypti.
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. Additionally, natural ZIKV infection has been documented in Aedes albopictus (Skuse) in Gabon (Grard et al. 2014) . These reports implicate these species as probable ZIKV vectors to humans in the Americas.
In late 2015, the continental United States identified the first imported cases of ZIKV (CDC 2018) . In 2016, Florida witnessed the beginnings of autochthonous transmission in Miami, FL. By the end of 2016, ZIKV transmission in Florida reached a new pinnacle with a total of 1,471 cases of ZIKV documented: 1,122 travel cases, 300 locally acquired cases, and 49 undetermined cases. ZIKV was not the first arbovirus to establish local transmission in Florida. In recent years, an outbreak of dengue virus was identified in Key West, FL, in 2009-2010 and then separately introduced in Martin County, FL, in the 2013 dengue outbreak (Radke et al. 2012 , Teets et al. 2014 . Other imported emerging vector-borne disease cases are being documented in Florida including chikungunya virus, although no locally acquired infections have been recorded (FDOH 2018a) . Imported cases of ZIKV into Florida continue to be identified. Combined with other factors such as abundant potential vector populations, favorable environment, and heavy tourism industry, reoccurrence of local transmission of ZIKV in Florida is a major public health risk. Because of its recent recognition as a pathogen causing serious human illness, there are substantial gaps in our understanding of interactions between ZIKV and potential mosquito vectors.
Factors such as ZIKV strain, titer of viral blood meal, and geographic location of vector populations can influence the vector competency within the same species as well as between different vector species (Boorman and Porterfield 1956 , Cornet et al. 1979 , Li et al. 2012 , Diagne et al. 2015 . For example, some studies report high susceptibility to ZIKV infection in Ae. aegypti (Li et al. 2012 , Di Luca et al. 2016 ) while other studies report low susceptibility to ZIKV infection in Ae. aegypti populations (Chouin-Carneiro et al. 2016) . Similar disparities in susceptibility to ZIKV infection within Ae. albopictus have been documented (Li et al. 2012 , Di Luca et al. 2016 ). These differences in susceptibility are likely attributable to varying geographic locations, ZIKV strain, and colony age , Ciota et al. 2017 , Li et al. 2017 . Studies, mostly from Africa and Asia, have demonstrated distinct differences in ZIKV vector competence of Ae. aegypti and Ae. albopictus. To date, only a single study has assessed ZIKV infection and transmission in Ae. aegypti and Ae. albopictus from Florida, using an isolate of ZIKV from New Caledonia (Chouin-Carneiro et al. 2016) . However, transmission rates for Ae. aegypti from Florida were not tested in this previous study. While this study used F1-F2 generation Aedes from American populations, the Florida-derived Ae. aegypti and Ae. albopictus had been maintained as laboratory colonies for several generations (F7-F10) and may not be representative of field populations (Vazeille et al. 2003) . This former study suggests huge variation in transmission potential among Aedes vector populations for ZIKV which is consistent with observations for transmission potential among vector populations for chikungunya virus (Vega-Rua et al. 2014) . These observations suggest that midgut escape and salivary gland transmission barriers are the primary determinants of variation in vector competence among these Aedes vectors. To date, no study has appraised the vector competence of Florida Ae. aegypti and Ae. albopictus for ZIKV. The purpose of this project is to investigate the susceptibility and transmission potential of Florida vectors, Ae. aegypti and Ae. albopictus, to ZIKV circulating in the Americas as a pilot study to improve risk prediction for ZIKV in Florida.
Materials and Methods

Mosquitoes
The F1 generation of Ae. aegypti and Ae. albopictus used for this experiment were the offspring of field-collected larvae from tires in a tire yard in Okeechobee, FL, in June 2016. Field-collected larvae were reared under controlled conditions with a 15:9 (L:D) h cycle at 28°C with approximately 80% RH. Pupae were transferred to clear plastic vials with water and a cotton seal and identified to species upon eclosion. Adults were transferred to Bugdorm insect rearing cages (30 cm 3 ) where they were permitted to mate and offered defibrinated bovine blood (Hemostat Laboratories, Dixon, CA) using hog casings heated to 37°C in a water bath. Adults were provided with a 10% sucrose solution and water using cotton wicks. The F1 eggs were collected from ovipositing females on germination paper placed in water-filled cups in the cages. To synchronize hatching, eggs were hatched in deoxygenated water prepared in an insulated vacuum container powered with an electronic pump. The F1 larvae were reared at 28°C with larval food consisting of equal parts brewer's yeast and liver powder at a density of approximately 200 larvae per liter of water and a 15:9 (L:D) h cycle. Pupae were transferred to water-holding cups and placed in Bugdorm cages for eclosion. Adults were supplied with a 10% sucrose solution and water and held until adults were 7-8 d old.
Virus
A low passage isolate of ZIKV from Puerto Rico (Asian lineage, GenBank: KU501215.1, strain PRVABC59) was used to infect the mosquitoes. An isolate of ZIKV was provided by the Centers for Disease Control and Prevention. The virus isolate was obtained in December 2015 from human serum. We deliberately chose this strain of ZIKV because it is responsible for outbreaks in the Americas (December 2015-present) and it is a risk for importation to Florida. ZIKV was propagated by inoculating monolayers of African green monkey (Vero) cells with 500 μl of diluted stock ZIKV. Following a 1-h incubation period at 37°C with a 5% CO 2 atmosphere, 24.5 ml media (M199 medium supplemented with 10% fetal bovine serum, penicillin/streptomycin, and mycostatin) were added to each T-175 cm 2 flask with cells and ZIKV and incubated for an additional 6 d, after which ZIKV was combined with bovine blood and used in an oral infection study with mosquitoes.
Oral Infection of Mosquitoes
We transferred cohorts of 7-to 8-d-old females of each species into cylindrical cages (10 cm height × 10 cm top diameter × 7 cm bottom diameter) with mesh tops and independently fed them on one of three ZIKV doses: 3.8 log 10 plaque-forming units (PFU) per ml (low titer), 5.5 log 10 PFU per ml (medium titer), or 6.9 log 10 PFU per ml (high titer). These doses of virus were chosen based on the range of viral titers found in human viremic hosts (Lanciotti et al. 2008) . Cages containing the mosquitoes were transferred to the biosafety level-3 facility at the Florida Medical Entomology Laboratory in Vero Beach, FL, 1 d prior to the feeding trials. Mosquitoes were maintained in an incubator at 28 ± 1°C with 15:9 (L:D) h cycle and approximately 80% RH. Mosquitoes were starved of sucrose 12 h prior to the infectious blood meal feeding, and water starved 1 h before offered the infectious blood meal. A fresh virus suspension was used to prepare the infectious blood meal consisting of defibrinated bovine blood and ZIKV. Adenosine triphosphate (ATP) at 0.005 M was added as a phagostimulant to the infected blood meals. Treatment groups were exposed to their corresponding ZIKV dose treatments using a Hemotek membrane feeding system (Hemotek Ltd., Lancashire, United Kingdom) warmed to 37°C. Feeding trials lasted for 1 h, after which mosquitoes were cold-anesthetized for sorting. Fully engorged mosquitoes were returned to the cages and given 10% sucrose solution for 13 d. Saliva infection was used as a proxy for transmission potential. To measure saliva infection, mosquitoes were cold-anesthetized and individually transferred into clear plastic tubes (h by d: 8 by 3 cm) with filter paper impregnated with honey mixed with blue food coloring 13 days post-infection (dpi). The blue food coloring was observable in the crop of the mosquito with aid of a flashlight and served as a marker to determine whether mosquito imbibed honey. Visualization of blue in the crop indicated the mosquito fed on honey solution and deposited saliva on the filter paper which was tested for the presence or absence of ZIKV. This methodology has been successfully used to measure transmission potential of chikungunya virus by both of these mosquito vectors (Alto et al. 2017 ). The mosquitoes were examined for blue in the crop 24 h after placement in the tubes (14 dpi). Only mosquitoes with blue present in the crop were tested for ZIKV saliva infection. Mosquitoes were stored at −80°C until processed.
Mosquito Processing
Susceptibility to infection, disseminated infection, and transmission potential for ZIKV were separately evaluated by examining the body, dissected legs, and saliva, respectively. Viral RNA was extracted from a 160 µl sample using a QIAamp Viral RNA Mini Kit (Thermo Fisher Scientific Inc.). Quantitative real-time polymerase chain reaction (qRT-PCR) methods were used to analyze the presence and quantity of ZIKV RNA using the Superscript III One-Step qRT-PCR with Platinum Taq kit by Invitrogen (Carlsbad, CA) per the manufacturer's protocol. Quantitative RT-PCR used the CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA) and primers and probes specific to the Asian lineage of ZIKV. Primers were designed to target the NS5 gene with the following sequences: forward primer, 5′-CTTCTTATCCACAGCCGTCTC-3′; reverse primer, 5′-CCAGGCTTCAACGTCGTTAT-3′; and probe 5′-/56-FAM/AGAAGGAGACGAGATGCGGTACAGG/3BHQ_1/-3′ (Integrated DNA Technologies, Coralville, IA). The program for qRT-PCR was as follows: 30 min at 50°C, 2.0 min at 94°C, 12 s at 94°C, 1 min at 58°C, and lastly repeated for 39 cycles. The cutoff for positive ZIKV samples was set at a Cq detection of 35 PCR cycles.
ZIKV Standard Curve
A standard curve methodology was used to translate Cq from qRT-PCR to estimate PFU equivalents per ml by plaque assay. We used 10-fold serial dilutions of viral stock for the qRT-PCR quantification of viral load. Viral RNA was extracted from each dilution using a QIAamp Viral RNA Mini Kit. The qRT-PCR primers and probe, along with the program are described in an earlier section. The same serial dilutions used for PCR were also used as the basis for a plaque assay. The plaque assay involved inoculating monolayers of Vero cells in six-well plates with 160 µl of serial dilution ZIKV (3-fold replication per dilution), followed by a 1-h incubation at 37°C and at a 5% CO 2 atmosphere. Following incubation, each well received a 2 ml agarose overlay (0.7%), and then incubated for six additional days. After incubation, media and agarose were removed and the plates were stained with crystal violet, rinsed with tap water, and visual plaques were enumerated. Each plaque is assumed to have originated from a single virus infection.
Statistical Analysis
The percent of infected mosquitoes was calculated by dividing the number of ZIKV positive mosquito bodies, legs, or saliva by the total number of mosquitoes sampled per treatment group. A contingency table analysis was used to evaluate factors of species, dose, and a species by dose interaction (PROC CATMOD, SAS 9.4). Significant factors were examined further using a pairwise comparison followup test. A sequential Bonferroni method was used to correct for multiple comparisons.
Results
Susceptibility to ZIKV Infection
All mosquito bodies were examined for the presence of ZIKV infection to measure susceptibility of ZIKV infection 14 d after oral exposure to the infected blood meal (Fig. 1) . A total sample size of 189 mosquito bodies were tested for the presence of ZIKV (116 Ae. aegypti, 73 Ae. albopictus). Ae. aegypti exposed to the low, medium, and high ZIKV dose treatment groups had body infection rates of 6.67% (n = 30), 26.47% (n = 34), and 75.8% (n = 33) infection rates, respectively. Ae. albopictus exposed to the low, medium, and high ZIKV dose treatment groups had body infection rates of 44.44% (n = 18), 4.55% (n = 22), and 53.85% (n = 33) infection rates, respectively. Results from the contingency table analysis show a significant difference between doses (df = 2, χ 2 = 30.94, P < 0.0001) Fig. 1 . Zika virus infection rates of Ae. aegypti and Ae. albopictus bodies from each treatment group (low, medium, and high doses) were examined to determine susceptibility to Zika virus infection. The number of individual mosquitoes tested are shown below the bars. P-values were evaluated by a pairwise comparison after correcting for multiple comparisons using the sequential Bonferroni method. and a species by dose interaction (df = 2, χ 2 = 10.18, P = 0.0062) but no significant differences between species was observed (df = 1, χ 2 = 0.86, P = 0.3529). After a pairwise comparison of dose, a significant difference between Ae. aegypti and Ae. albopictus given a low dose of ZIKV was observed (df = 1, χ 2 = 7.67, P = 0.0056). At low doses of ZIKV, Ae. albopictus had higher rates of body infection than Ae. aegypti (44.44% and 6.67%, respectively). Additionally, a significant difference between Ae. aegypti and Ae. albopictus given a high dose of ZIKV was also observed (df = 1, χ 2 = 4.01, P = 0.0454). At high doses of ZIKV, Ae. aegypti had higher rates of body infection than Ae. albopictus (75.8% and 53.85%, respectively). No significant differences (df = 1, χ 2 = 3.41, P = 0.0647) were observed between Ae. aegypti and Ae. albopictus given the medium ZIKV titer.
Disseminated Infection
The legs of the ZIKV positive bodies were tested for disseminated infection (Fig. 2) in Ae. aegypti and Ae. albopictus (44 Ae. aegypti, 37 Ae. albopictus). Ae. aegypti exposed to the low, medium, and high ZIKV dose treatment groups had disseminated infection rates of 25% (n = 8), 75% (n = 8), and 75% (n = 28) infection rates, respectively. Ae. albopictus exposed to the low, medium, and high ZIKV dose treatment groups had disseminated infection rates of 11.11% (n = 9), 0% (n = 2), and 23.08% (n = 26) infection rates, respectively. Results from the contingency table analysis showed no significant difference between species (df = 1, χ 2 = 0.15, P = 0.7020), dose (df = 2, χ 2 = 4.33, P = 0.1148), or a species by dose interaction (df = 2, χ 2 = 0.84, P = 0.6572).
Saliva Infection
The saliva of mosquitoes that tested positive for disseminated infection and contained blue in the crop were tested for the presence of ZIKV (Fig. 3) . Ae. aegypti exposed to the low, medium, and high ZIKV dose treatment groups had salivary infection rates of 0% (n = 1), 20% (n = 5), and 52.4% (n = 21) infection rates, respectively.
Ae. albopictus exposed high ZIKV dose treatment groups had a 40% (n = 5) salivary infection rate. Ae. albopictus treatment groups provided the low and medium ZIKV dose did not present with blue in the gut; therefore, these groups did not have any saliva to test for the presence of ZIKV. Saliva of Ae. aegypti in the low ZIKV dose treatment group did not test positive for ZIKV. Results from the contingency table analysis showed no significant difference between species (df = 1, χ 2 = 0.15, P = 0.9123), dose (df = 2, χ 2 = 0.02, P = 0.9925), or a species by dose interaction (df = 2, χ 2 = 0.02, P = 0.9925).
Discussion
Recent outbreaks of ZIKV have increased the need to examine potential vector populations for susceptibility and transmission potential of this rapidly spreading arbovirus. Florida has been on the frontline for local transmission in the continental United States, with populations of mosquitoes in Miami, FL, responsible for the first localized outbreak and autochthonous transmission of ZIKV in 2016. Florida is home to established populations of two putative vectors of ZIKV, Ae. aegypti and Ae. albopictus. In addition to having a favorable environment for arbovirus transmission, Florida is a hub for international travel and tourism, facilitating imported cases. These factors contribute to the need to investigate the competency of these potential vector populations in Florida, an area of concern for vector-borne disease outbreaks.
This study compared the susceptibility to infection, disseminated infection rates, and saliva infection rates of ZIKV in Ae. aegypti and Ae. albopictus populations from Okeechobee, FL, to evaluate the capacity of ZIKV to advance in a location where these two mosquito populations coexist. The results of this study show both mosquito species examined are susceptible to the Asian lineage of ZIKV strain circulating in the Americas, can disseminate the infection, and potentially transmit the virus. Additionally, the results demonstrate a clear dose-response pattern of infection. This pattern is clearly shown in Ae. aegypti mosquitoes where the treatment groups exposed to the low titer of ZIKV had lower susceptibility to infection while treatment groups exposed to medium titers displayed moderate susceptibility and exposure to high titers exhibited the highest susceptibility to ZIKV infection. Similar trends were observed for disseminated infection rate and salivary infection rate in both mosquito species.
Interestingly, Ae. albopictus had significantly higher rates of susceptibility to ZIKV infection compared to Ae. aegypti at low, but not higher doses. Chouin-Carneiro et al. (2016) orally exposed Ae. aegypti and Ae. albopictus from the Americas, including Florida, to ZIKV (New Caledonia strain) to assess infection and transmission rates. Mosquitoes were provided an infectious blood meal with a final concentration of 7 log 10 PFU per ml and held at 28°C for 14 d. Results showed higher infection of Ae. aegypti (70-80%) than Ae. albopictus (20-85%), consistent with our observations of higher infection rates of Ae. aegypti than Ae. albopictus given a high infectious dose. However, this study used a different population of Florida mosquitoes that had been colonized for F7-F10 generations which may have contributed to greater variation in infection rates for Ae. albopictus. Additionally, Di Luca et al. (2016) found similarly low disseminated infection rates (29%) in an Italian population of Ae. albopictus sampled 14 d after orally exposed to 6.46 log 10 PFU per ml of ZIKV of Asian lineage from French Polynesia.
Aedes albopictus seem to have barriers to disseminated infection of ZIKV. This is especially prevalent in treatment groups given the medium titer of ZIKV; however, these trends were not significant according to the contingency table analysis and are likely attributable to low sample size. These differences in barriers to transmission can be further investigated. Overall, Ae. aegypti had higher rates of susceptibility to ZIKV infection, disseminated infection, and salivary infection rates compared to Ae. albopictus in this population. These trends were not found to be significant in the statistical analysis, so we can only cautiously suggest that Ae. aegypti seems to be a more susceptible vector in this Florida population. This is a cause for concern due to this species highly anthropophilic behavior, including a preference for feeding on human hosts even when other hosts are available. Lanciotti et al. (2008) collected blood samples from human viremic hosts during the 2007 Yap State, Micronesia ZIKV outbreak. Researchers found mean ZIKV titers to be approximately 4.4 log 10 PFU per ml of ZIKV with low titers recorded at 2.9 log 10 PFU per ml and high titers at 5.8 log 10 PFU per ml. This range of viremia approximates the low and high doses used in the current experiment. Other studies investigating susceptibility of mosquitoes to ZIKV typically use a single dose at a moderately high titer (7 log 10 PFU per ml, 7 log 10 TCID 50 per ml) (Li et al. 2012 , Chouin-Carneiro et al. 2016 . In nature, viral titers vary and are typically not as high as the viral titers used in laboratory studies (Lanciotti et al. 2008) . Using high titers of virus for mosquito infection studies allows for higher rates of infection than what is typically observed in nature and can be useful for collecting transmission data. However, the use of a single high dose of infected blood may yield misleading results given our detection of an interaction between virus dose and vector species for susceptibility to infection. In this study, these differences were not observed for disseminated infection and transmission potential and so the net effect on vector. Our study offered a range of ZIKV titers a vector may feed on during an outbreak period and offers insight to the ranges of vector infection we might observe. Additionally, the mosquitoes used in our study were low generation progeny from field-collected mosquitoes. Vazeille et al. (2003) showed that dengue-2 infection rates of Ae. albopictus were up to 4-fold different in recently collected versus older laboratory strains, suggesting that laboratory colonization alters susceptibility to infection. This study has strengthened the need to investigate the vector competency of other potential ZIKV vector populations across Florida, given the potential for geographic variation in vector competence for other arboviruses transmitted by these species (e.g., chikungunya virus, Alto et al. 2017) , to identify high risk areas for ZIKV outbreaks and help contribute to better vector control strategies.
